These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37597591)

  • 1. Impact of guideline-directed medical therapy on 5-year mortality in patients with newly diagnosed peripheral artery disease.
    Lee JH; Jeon HS; Lee JW; Youn YJ; Ahn SG; Kim H; Bae Y; Kim U; Ahn CM; Ko YG
    J Vasc Surg; 2023 Dec; 78(6):1471-1478.e3. PubMed ID: 37597591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Guideline-Directed Medical Therapy on 10-Year Mortality after Revascularization for Patients with Chronic Limb-Threatening Ischemia.
    Hata Y; Iida O; Okamoto S; Ishihara T; Nanto K; Tsujimura T; Higashino N; Toyoshima T; Kitano I; Tsuji Y; Takahara M; Mano T
    J Atheroscler Thromb; 2023 Jun; 30(6):663-674. PubMed ID: 36031358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
    Chen DC; Singh GD; Armstrong EJ; Waldo SW; Laird JR; Amsterdam EA
    Am J Cardiol; 2017 Apr; 119(8):1146-1152. PubMed ID: 28259239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.
    Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A
    Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease.
    Koutroumpakis E; Gosmanova EO; Stahura H; Jou S; Alreshq R; Ata A; Sidhu MS; Philbin E; Boden WE; Lyubarova R
    Cardiovasc Drugs Ther; 2019 Aug; 33(4):443-451. PubMed ID: 31123935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the relationship between sex and prescriptions for guideline-recommended therapy in peripheral arterial disease, in relation to 1-year all-cause mortality: a primary care cohort study.
    Benson RA; Okoth K; Keerthy D; Gokhale K; Adderley NJ; Nirantharakumar K; Lasserson DS
    BMJ Open; 2022 Mar; 12(3):e055952. PubMed ID: 35273054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a Quality Improvement Initiative on Medical Management of Veterans With Peripheral Artery Disease.
    Hoang L; Mani B; Wilson G; Ogu JC; Banerjee S; Ramanan B; Modrall JG; Timaran CH; Tsai S
    Am J Cardiol; 2024 Jun; 221():44-49. PubMed ID: 38636628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.
    Hussain MA; Al-Omran M; Mamdani M; Eisenberg N; Premji A; Saldanha L; Wang X; Verma S; Lindsay TF
    JAMA Surg; 2016 Aug; 151(8):742-50. PubMed ID: 27050566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription Rates and Prognostic Implications of Optimally Targeted Guideline-Directed Medical Treatment in Heart Failure and Atrial Fibrillation: Insights From The MISOAC-AF Trial.
    Moysidis DV; Kartas A; Samaras A; Papazoglou AS; Patsiou V; Bekiaridou A; Baroutidou A; Tsagkaris C; Karagiannidis E; Daios S; Anastasiou V; Tsalikakis D; Efthimiadis G; Ziakas A; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol; 2023 Mar; 81(3):203-211. PubMed ID: 36626410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains.
    Subherwal S; Patel MR; Kober L; Peterson ED; Jones WS; Gislason GH; Berger J; Torp-Pedersen C; Fosbol EL
    Circulation; 2012 Sep; 126(11):1345-54. PubMed ID: 22874581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Peripheral Artery Disease in Patients With Heart Failure Undergoing Transcatheter Mitral Valve Repair: The COAPT Trial.
    Shahim B; Cohen DJ; Ben-Yehuda O; Redfors B; Kar S; Lim DS; Arnold SV; Li Y; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    J Am Heart Assoc; 2023 Feb; 12(4):e028444. PubMed ID: 36752227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia: A Review.
    Polonsky TS; McDermott MM
    JAMA; 2021 Jun; 325(21):2188-2198. PubMed ID: 34061140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Underutilization of Medical Therapy in Patients Undergoing Endovascular Revascularization for Peripheral Artery Disease.
    Altin SE; Castro-Dominguez YS; Kennedy KF; Orion KC; Lanksy AJ; Abbott JD; Aronow HD
    JACC Cardiovasc Interv; 2020 Dec; 13(24):2911-2918. PubMed ID: 33357529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery.
    Moshkovitz Y; Orenstein L; Olmer L; Laufer K; Ziv A; Dankner R
    Mayo Clin Proc; 2024 May; 99(5):766-779. PubMed ID: 38456874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline-directed medical therapy after transcatheter edge-to-edge mitral valve repair.
    Tanaka T; Kavsur R; Spieker M; Iliadis C; Metze C; Brachtendorf BM; Horn P; Zachoval C; Sugiura A; Kelm M; Baldus S; Nickenig G; Westenfeld R; Pfister R; Becher MU
    Heart; 2022 Oct; 108(21):1722-1728. PubMed ID: 35672114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease.
    Cutshall BT; Duhart BT; Saikumar J; Samarin M; Hutchison L; Hudson JQ
    Am J Med Sci; 2018 Mar; 355(3):247-251. PubMed ID: 29549927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guideline-Directed Medical Therapy and Long-Term Mortality and Amputation Outcomes in Patients Undergoing Peripheral Vascular Interventions.
    Smolderen KG; Romain G; Provance JB; Scierka LE; Mao J; Goodney PP; Henke PK; Sedrakyan A; Mena-Hurtado C
    JACC Cardiovasc Interv; 2023 Feb; 16(3):332-343. PubMed ID: 36792257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a cohort study.
    Seo WW; Park JJ; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    BMJ Open; 2020 Feb; 10(2):e030514. PubMed ID: 32034017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction.
    Balakumaran K; Patil A; Marsh S; Ingrassia J; Kuo CL; Jacoby DL; Arora S; Soucier R
    Int J Cardiol Heart Vasc; 2019 Mar; 22():1-5. PubMed ID: 30480083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.